INVACARE CORP (IVC) 0.35 +0.01 (+2.88%)
0.35 +0.01 (+2.88%)
US4612031017 - Common Stock
Fundamental Rating
We assign a fundamental rating of 2 out of 10 to IVC. IVC was compared to 221 industry peers in the Health Care Equipment & Supplies industry. IVC has a bad profitability rating. Also its financial health evaluation is rather negative. IVC is valued expensive and it does not seem to be growing.
Profitability
Profitability Rating
IVC's Profit Margin of -9.99% is amongst the best of the industry. IVC does better than the industry average Profit Margin of -28.67%.
IVC has a Return On Assets of -10.37%. This is comparable to the industry average of -18.33%.
The profitability ratios for IVC are negative, so there is not much use analyzing them.
The Piotroski-F score of IVC is 3.00. This is a low score and indicates issues in the health and profitability of IVC.
VS Industry
ROA (-10.37%) VS Industry: 60% outperformed.
-771.54
117.69
Profit Margin (-9.99%) VS Industry: 64% outperformed.
-142,068.42
1,450.19
Valuation
Valuation Rating
With a price book ratio of 0.16, IVC is valued rather cheaply.
Compared to an average industry price book ratio of 2.66, IVC is valued rather cheaply. On top of this, IVC is cheaper than 99% of the companies listed in the same industry.
The Price/Earnings Ratio is negative for IVC. In the last year negative earnings were reported.
Also next year IVC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
VS Industry
Price/Book (0.16) VS Industry: 99% outperformed.
1,042.45
0.08
Growth
Growth Rating
When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
The Earnings Per Share is expected to decrease by -9.63% on average over the next 5 years.
IVC shows a decrease in Revenue. In the last year, the revenue decreased by -9.61%.
Measured over the past 5 years, IVC shows a decrease in Revenue. The Revenue has been decreasing by -3.59% on average per year.
The Revenue is expected to grow by 0.86% on average over the next 5 years.
The earnings per share for IVC have decreased strongly by -137.21% in the last year.
| Past | Future | ||||||
|---|---|---|---|---|---|---|---|
| 5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |
| EPS | N/A | N/A | -137.21% | -185.67% | -13.68% | 8.78% | -9.63% |
| Revenue | -3.59% | -3.55% | -9.61% | -9.96% | -3.46% | 0.38% | 0.86% |
Health
Health Rating
A Current Ratio of 1.32 indicates that IVC should not have too much problems paying its short term obligations.
IVC has a Altman-Z score comparable to the industry average, which is at 1.80.
When comparing the Current Ratio of IVC to the average industry Current Ratio of 3.66, IVC is less able to pay its short term obligations than its industry peers. 90% of its industry peers have a better Current Ratio.
A Quick Ratio of 0.78 indicates that IVC may have some problems paying its short term obligations.
When comparing the Quick Ratio of IVC to the average industry Current Ratio of 2.92, IVC is less able to pay its short term obligations than its industry peers. 91% of its industry peers have a better Quick Ratio.
IVC has one of the worst Debt to Equity ratios in its industry. 97% of its industry peers require less debt for financing their operations.
IVC has an Altman-Z score of 0.89. This is a bad value and indicates that IVC is not financially healthy and even has some risk of bankruptcy.
IVC has a quite weak Piotroski-F score of 3.00. This indicates issues in the health and profitability of IVC.
VS Industry
Debt/Equity (4.82) VS Industry: 3% outperformed.
336.87
0.00
Quick Ratio (0.78) VS Industry: 9% outperformed.
0.06
31.22
Current Ratio (1.32) VS Industry: 10% outperformed.
0.13
31.22
Altman-Z (0.89) VS Industry: 42% outperformed.
-105.06
70.07
Dividend
Dividend Rating
No dividends for IVC!.
INVACARE CORP0.35
NYSE:IVC (11/30/2022, 7:04:00 PM)+0.01 (+2.88%)
| GICS Sector | Health Care | ||
| GICS IndustryGroup | Health Care Equipment & Services | ||
| GICS Industry | Health Care Equipment & Supplies | ||
| Earnings (Last) | 11-07 2022-11-07/amc | Earnings (Next) | 03-06 2023-03-06 |
| Ins Owners | 7.36% | Inst Owners | 49.79% |
| Market Cap | 13.22M | Analysts | 80 |
| PE | N/A | Fwd PE | N/A |
| PEG (NY) | N/A | PEG (5Y) | N/A |
| P/S | 0.02 | P/B | 0.16 |
| EV/EBITDA | -16.87 | ||
| Dividend Yield | N/A | Dividend Growth | N/A |
| DP | 0% | Ex-Date | N/A |
| EPS 1Y | -137.21% | EPS 3Y | N/A |
| EPS 5Y | N/A | EPS growth Q2Q | -666.67% |
| EPS Next Y | -185.67% | EPS Next 2Y | -13.68% |
| EPS Next 3Y | 8.78% | EPS Next 5Y | -9.63% |
| Revenue growth 1Y | -9.61% | Revenue growth 3Y | -3.55% |
| Revenue growth 5Y | -3.59% | Revenue growth Q2Q | -23.99% |
| Revenue Next Year | -9.96% | Revenue Next 2Y | -3.46% |
| Revenue Next 3Y | 0.38% | Revenue Next 5Y | 0.86% |
| Current Ratio | 1.32 | Quick Ratio | 0.78 |
| Altman-Z | 0.89 | F-Score | 3 |
| Debt/Equity | 4.82 | WACC | 5.4% |
| ROIC/WACC | N/A | ||
| ROA | -10.37% | ROE | N/A |
| ROICexgc | N/A | ROIC | N/A |
| PM | -9.99% | OM | -4.79% |
| Asset Turnover | 1.04 | ||
Fundamental Stock Screener Links
Fundamental Stock Screener
Find stocks with similar Fundamental rating on the USA
Best Fundamental Competitors Stock Screener
Find the competitors with the best fundamentals on the USA
Best Valuation Competitors Stock Screener
Find the competitors with the best valuation on the USA
Best Dividend Competitors Stock Screener
Find the competitors with the best dividend on the USA